Screening for Down's syndrome.
作者信息
Cuckle H
出版信息
BMJ. 1992 Dec 12;305(6867):1504. doi: 10.1136/bmj.305.6867.1504.
Abstract
摘要
相似文献
1
Screening for Down's syndrome.唐氏综合征筛查
BMJ. 1992 Dec 12;305(6867):1504. doi: 10.1136/bmj.305.6867.1504.
2
Screening for Down's syndrome.唐氏综合征筛查
Br Med J (Clin Res Ed). 1985 Dec 14;291(6510):1725. doi: 10.1136/bmj.291.6510.1725-b.
3
Antenatal screening for Down's syndrome.唐氏综合征的产前筛查
Mod Midwife. 1995 Jun;5(6):23-6.
4
5
Maternal serum screening policy for Down's syndrome.唐氏综合征的母血清筛查政策。
Lancet. 1992 Sep 26;340(8822):799. doi: 10.1016/0140-6736(92)92349-k.
6
Provision of screening for Down's syndrome.唐氏综合征筛查服务。
BMJ. 1995 Aug 19;311(7003):512. doi: 10.1136/bmj.311.7003.512b.
7
Implementation of an antenatal serum screening programme for Down's syndrome in two districts (Brighton and Eastbourne). The Brighton and Eastbourne Down's Syndrome Screening Group.在两个地区（布莱顿和伊斯特本）实施唐氏综合征产前血清筛查项目。布莱顿和伊斯特本唐氏综合征筛查小组。
J Med Screen. 1994 Jan;1(1):45-9. doi: 10.1177/096914139400100109.
8
Maternal serum screening for neural tube defects and Down's syndrome.用于神经管缺陷和唐氏综合征的母血清筛查。
Med J Aust. 1991 Aug 19;155(4):279-80.
9
Effect of non-invasive prenatal testing as a contingent approach on the indications for invasive prenatal diagnosis and prenatal detection rate of Down's syndrome.作为一种替代方法的无创产前检测对唐氏综合征侵入性产前诊断指征及产前检出率的影响。
Hong Kong Med J. 2016 Jun;22(3):223-30. doi: 10.12809/hkmj154730. Epub 2016 May 6.
10
Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.使用母体血清甲胎蛋白、人绒毛膜促性腺激素和未结合雌三醇进行产前筛查：在一家健康维护组织中的两年经验。
J Matern Fetal Med. 1996 Mar-Apr;5(2):70-3. doi: 10.1002/(SICI)1520-6661(199603/04)5:2<70::AID-MFM4>3.0.CO;2-N.
引用本文的文献
1
Risk assessment adjusted for gestational age in maternal serum screening for Down's syndrome.孕母血清唐氏综合征筛查中针对孕周进行的风险评估调整。
BMJ. 1993 Jun 5;306(6891):1509-11. doi: 10.1136/bmj.306.6891.1509.
本文引用的文献
1
Results of first year (1989) of a national register of Down's syndrome in England and Wales.英格兰和威尔士唐氏综合征国家登记处第一年（1989年）的结果。
BMJ. 1991 Nov 23;303(6813):1295-7. doi: 10.1136/bmj.303.6813.1295.
2
Antenatal screening for Down's syndrome.唐氏综合征的产前筛查
BMJ. 1992 Oct 24;305(6860):1017. doi: 10.1136/bmj.305.6860.1017.
3
Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy.胎儿颈部透明带：孕早期染色体缺陷的超声筛查
BMJ. 1992 Apr 4;304(6831):867-9. doi: 10.1136/bmj.304.6831.867.
4
The extent of Down's syndrome screening in Britain in 1991.1991年英国唐氏综合征筛查的范围。
Lancet. 1992 Aug 22;340(8817):494. doi: 10.1016/0140-6736(92)91822-p.
5
Non-echogenic nuchal oedema as a marker in trisomy 21 screening.无回声颈部水肿作为21三体筛查的一个标志物。
Lancet. 1992 Jun 13;339(8807):1480-1. doi: 10.1016/0140-6736(92)92074-p.
6
Non-echogenic nuchal oedema as a marker in trisomy 21 screening.无回声颈部水肿作为21三体综合征筛查的一个标志物。
Lancet. 1992 Apr 25;339(8800):1053. doi: 10.1016/0140-6736(92)90574-m.
Zotero 插件